Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 2

1(33.3%)

3Total

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT02599480Phase 2Completed

Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure

Role: collaborator

NCT06748924Recruiting

Chronic Coronary Syndrome Snapshot Study

Role: lead

NCT06601270Recruiting

SCAD : a Registry of Spontaneous Coronary Artery Dissection

Role: lead

NCT06495177Recruiting

European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)

Role: lead

NCT06469814Not Yet Recruiting

Snapshot Study on Patients With Heart Failure

Role: lead

NCT04396418Not ApplicableActive Not Recruiting

Stroke Prevention and Rhythm Control Therapy STEEER-AF

Role: lead

NCT03434314Not ApplicableActive Not Recruiting

Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging

Role: collaborator

NCT04437901Unknown

COVIDAR - Arrhythmias in COVID-19

Role: collaborator

NCT02518984Completed

Atrial Fibrillation General Registry

Role: lead

NCT03280368Completed

Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation

Role: collaborator

NCT03511885Completed

EUROASPIRE V Survey on Cardiovascular Disease Prevention and Diabetes

Role: collaborator

All 11 trials loaded